Ohr Pharmaceutical Announces New Positive Anatomic And Visual Acuity Data On OHR-102 IMPACT Study Presented At The 2014 American Academy Of Ophthalmology Scientific Meeting

By: via Benzinga
Ohr Pharmaceutical, Inc. (Nasdaq: OHRP), an ophthalmology research and development company, announced today that additional positive ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.